Clinical trials
Phase 2 Body Weight trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Terminated | 2 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 3 |
| Eli Lilly and Company | 2 |
| KGK Science Inc. | 2 |
| Regeneron Pharmaceuticals | 2 |
| Aardvark Therapeutics, Inc. | 1 |
| Abdelrahman Mahmoud | 1 |
| Ajinomoto USA, INC. | 1 |
| Biomed Industries, Inc. | 1 |
| GlaxoSmithKline | 1 |
| Healios K.K. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Body Weight | 34 |
| Obesity | 18 |
| Overweight | 13 |
| Nutrition Disorders | 6 |
| Metabolic Diseases | 4 |
| Nutritional and Metabolic Diseases | 4 |
| Weight Loss | 4 |
| Overnutrition | 3 |
| Body Weight Changes | 2 |
| Diabetes Mellitus | 2 |
Trials
Showing 26 to 34 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.